RELIEF THERAPEUTICS (UK) Insiders

RELIEF THERAPEUTICS Management Team Effectiveness

The company has return on total asset (ROA) of (0.0735) % which means that it has lost $0.0735 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.3852) %, meaning that it generated substantial loss on money invested by shareholders. RELIEF THERAPEUTICS's management efficiency ratios could be used to measure how well RELIEF THERAPEUTICS manages its routine affairs as well as how well it operates its assets and liabilities. At this time, RELIEF THERAPEUTICS's Total Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 56.4 M in 2025, whereas Total Current Assets are likely to drop slightly above 15.7 M in 2025. Common Stock Shares Outstanding is likely to gain to about 13.2 M in 2025, despite the fact that Net Loss is likely to grow to (29.7 M).

RELIEF THERAPEUTICS Workforce Comparison

The company has Profit Margin (PM) of (2.03) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.27) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.27.

RELIEF THERAPEUTICS Benchmark Summation

RELIEF THERAPEUTICS Notable Stakeholders

The success or failure of an entity such as RELIEF THERAPEUTICS often depends on how effective the management is. RELIEF THERAPEUTICS management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of RELIEF management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the RELIEF management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in RELIEF THERAPEUTICS's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of RELIEF THERAPEUTICS Holding. Check RELIEF THERAPEUTICS's Beneish M Score to see the likelihood of RELIEF THERAPEUTICS's management manipulating its earnings.

When running RELIEF THERAPEUTICS's price analysis, check to measure RELIEF THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RELIEF THERAPEUTICS is operating at the current time. Most of RELIEF THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of RELIEF THERAPEUTICS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RELIEF THERAPEUTICS's price. Additionally, you may evaluate how the addition of RELIEF THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.